Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Gan To Kagaku Ryoho ; 50(13): 1774-1776, 2023 Dec.
Article in Japanese | MEDLINE | ID: mdl-38303203

ABSTRACT

The case is a woman in her 60s. Sigmoid colon cancer surgery, liver metastasis surgery, and adjuvant chemotherapy were performed at another hospital 2 years ago. Later, she developed a metastasis in her liver and was recommended surgery, but she refused treatment and was transferred. Her liver metastasis had invaded the stomach and formed a giant gastric ulcer. This time she had an adhesive ileus and underwent laparoscopic surgery at our hospital. At that time, we observed the state of liver metastasis and gastric infiltration by laparoscopy, so we thought that palliative surgery was possible and recommended it. Although she initially refused treatment, the relative ease with which her ileus surgery was performed encouraged her to undergo palliative surgery. Laparoscopic-assisted gastrectomy and partial hepatectomy were performed, and she was discharged on hospital day 13 after surgery. She subsequently developed liver metastases and died 8 months after palliative surgery, although she was able to eat and maintain her ADL until the end of life. By staying close to the patient, we were able to lead the patient from refusal of surgery to palliative surgery, and we felt that we were able to make the patient reach a favorable end.


Subject(s)
Ileus , Liver Neoplasms , Sigmoid Neoplasms , Female , Humans , Ileus/etiology , Ileus/surgery , Liver Neoplasms/secondary , Sigmoid Neoplasms/drug therapy , Stomach/pathology , Middle Aged , Aged
3.
Sci Rep ; 12(1): 7363, 2022 May 05.
Article in English | MEDLINE | ID: mdl-35513412

ABSTRACT

As a newly developed technique to slice GaN substrates, which are currently very expensive, with less loss, we previously reported a laser slicing technique in this journal. In the previous report, from the perspective of GaN substrate processing, we could only show that the GaN substrate could be sliced by a laser and that the sliced GaN substrate could be reused. In this study, we newly investigated the applicability of this method as a device fabrication process. We demonstrated the thinning of GaN-on-GaN high-electron-mobility transistors (HEMTs) using a laser slicing technique. Even when the HEMTs were thinned by laser slicing to a thickness of 50 mm after completing the fabrication process, no significant fracture was observed in these devices, and no adverse effects of laser-induced damage were observed on electrical characteristics. This means that the laser slicing process can be applied even after device fabrication. It can also be used as a completely new semiconductor process for fabricating thin devices with thicknesses on the order of 10 mm, while significantly reducing the consumption of GaN substrates.

4.
Heliyon ; 6(1): e03094, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31909264

ABSTRACT

A photovoltaic power generation system suitable for mobile applications was developed. A SiC integrated converter with the maximum power point tracking circuit provided the smallest photovoltaic inverter in ~200 W level. The SiC-based inverter exhibited a peak direct current (DC)-alternating current (AC) conversion efficiency higher than that of conventional Si inverters. A Li-ion laminated battery was mounted in the same housing as the inverter. The weight of entire system containing spherical Si solar cell panels was well below 6 kg. Continuous operation measurements of this system were carried out using four solar cell modules connected in parallel under irradiation by natural sunlight. The total inverter efficiencies under realistic operation conditions were slightly decreased compared with the DC-AC converter values because of loss by the maximum power point tracking device. Even under unstable weather conditions, the system provided power stability without ripples. The behaviors of the output powers of the solar cell, storage battery, and inverter modules were analyzed as a function of the solar radiation power density. The substantial efficiencies of the solar cell modules were dependent on the weather conditions and were approximately 10% on cloudy days. The present compact photovoltaic power generation system with SiC device and spherical Si solar cells is viable for sub kW-class inverter.

6.
Auris Nasus Larynx ; 43(4): 418-21, 2016 Aug.
Article in English | MEDLINE | ID: mdl-26559748

ABSTRACT

OBJECTIVE: Although sleep impairment is reported by patients with chronic rhinosinusitis, the associated factors have not been well studied. Therefore, we determined the associated risk factors for sleep impairment in patients with chronic rhinosinusitis (CRS). METHODS: This study was a prospective cohort study. A total of 572 adult patients (171 women, 401 men; mean age, 49.0 years; range, 18-64 years) who completed a questionnaire, had a clinical examination, and underwent endoscopic sinus surgery were analyzed using stepwise multiple linear regression. RESULTS: With regard to subjective symptoms, nasal obstruction (beta coef., 0.27; p<0.001), anterior nasal drainage (beta coef., 0.13; p=0.004), facial pain/pressure (beta coef., 0.09; p=0.048), headache (beta coef., 0.10; p=0.010), and cough (beta coef., 0.14; p<0.001) were predictors of an increased risk of sleep impairment of CRS (adjusted R(2), 0.240; p=0.048). In the matter of background parameters, total polyp score (polyp grading system) (beta coef., 0.16; p<0.001) and allergic rhinitis (beta coef., 0.09; p=0.034) were predictors of an increased risk of sleep impairment of CRS (adjusted R(2), 0.029; p=0.034). CONCLUSION: These results suggest that sleep impairment in these patients is caused by the various mechanisms associated with nasal symptoms themselves, CRS and allergic rhinitis. However, the specific pathophysiology has not been clarified yet; further studies are expected to elucidate that of sleep impairment in patients with CRS.


Subject(s)
Cough/epidemiology , Facial Pain/epidemiology , Headache/epidemiology , Nasal Obstruction/epidemiology , Rhinitis/epidemiology , Sinusitis/epidemiology , Adolescent , Adult , Chronic Disease , Cohort Studies , Endoscopy , Female , Humans , Linear Models , Male , Middle Aged , Multivariate Analysis , Nasal Polyps/epidemiology , Nasal Polyps/physiopathology , Nasal Polyps/surgery , Prospective Studies , Rhinitis/physiopathology , Rhinitis/surgery , Rhinitis, Allergic/epidemiology , Rhinitis, Allergic/physiopathology , Risk Factors , Sinusitis/physiopathology , Sinusitis/surgery , Sleep Wake Disorders , Surveys and Questionnaires , Young Adult
7.
Auris Nasus Larynx ; 43(3): 298-303, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26527519

ABSTRACT

OBJECTIVE: Hemostasis is difficult in patients with bleeding emanating from the deep regions in the nasal cavity; however, there is no standard treatment method. We studied hemostasis procedures in patients who visited our outpatient department and presented with idiopathic epistaxis extending from the posterior nasal cavity to Kiesselbach's area. METHODS: The subjects were patients with epistaxis who visited our hospital between June 2008 and May 2010. We asked specific questions at the time of the hospital visit and examined patients using a nasal speculum, a flexible endoscope, and a rigid endoscope (0 or 70 degree) to identify bleeding sites. Hemostasis using electrocoagulation was selected as the first-line therapy for patients in whom a bleeding point had been identified, whereas hemostasis using a gauze tampon was performed in patients in whom the bleeding point was unknown. The subjects were analyzed by multivariate logistic regression analysis. RESULTS: The bleeding point was unknown in most cases of recurrent posterior epistaxis. Electrocoagulation was the best hemostasis procedure. Identifying the bleeding points as much as possible and performing electrocoagulation at these sites was the preferred procedures. CONCLUSION: We propose the treatment procedure for refractory epistaxis. When it is difficult to identify a bleeding point in a patient with refractory epistaxis due to a deviated nasal septum, a bleeding point should be identified after septoplasty; for bleeding from the sphenopalatine artery region, electrocoagulation or endoscopic cauterization of the sphenopalatine artery should be performed.


Subject(s)
Balloon Occlusion , Electrocoagulation , Epistaxis/therapy , Nasal Cavity/surgery , Nasal Mucosa/surgery , Nasal Septum/surgery , Tampons, Surgical , Cautery/methods , Endoscopy , Female , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Recurrence , Rhinoplasty
8.
Case Rep Otolaryngol ; 2015: 125023, 2015.
Article in English | MEDLINE | ID: mdl-26473084

ABSTRACT

Apert syndrome is a congenital syndrome characterized by craniosynostosis and craniofacial dysostosis, among other features, and is reported to cause obstructive sleep apnea (OSA) because of upper airway narrowing associated with midfacial dysplasia. We recently encountered a case involving a patient with Apert syndrome complicated by OSA who began to receive continuous positive airway pressure (CPAP) therapy at the age of 4. OSA resolved after maxillofacial surgery performed at the age of 11, and CPAP was eventually withdrawn. In pediatric patients with maxillofacial dysplasia complicated by OSA, a long-term treatment plan including CPAP in addition to maxillofacial plastic and reconstructive surgery should be considered in view of the effects of OSA on growth.

9.
Bone ; 61: 82-90, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24389414

ABSTRACT

Distraction osteogenesis (DO) successfully induces large-scale skeletal tissue regeneration, but it involves an undesirably long treatment period. A high-speed DO mouse model (H-DO) with a distraction speed twice that of a control DO model failed to generate new bone callus in the distraction gap. Here we demonstrate that the local administration of serum-free conditioned medium from human mesenchymal stem cells (MSC-CM) accelerated callus formation in the mouse H-DO model. Secretomic analysis identified factors contained in MSC-CM that recruit murine bone marrow stromal cells (mBMSCs) and endothelial cells/endothelial progenitor cells (EC/EPCs), inhibit inflammation and apoptosis, and promote osteoblast differentiation, angiogenesis, and cell proliferation. Functional assays identified MCP-1/-3 and IL-3/-6 as essential factors in recruiting mBMSCs and EC/EPCs. IL-3/-6 also enhanced the osteogenic differentiation of mBMSCs. MSC-CM that had been depleted of MCP-1/-3 failed to recruit mBMSCs, and consequently failed to promote callus formation. Taken together, our data suggest that MSCs produce a broad repertoire of trophic factors with tissue-regenerative activities that accelerate healing in the DO process.


Subject(s)
Bone and Bones/metabolism , Culture Media, Conditioned/pharmacology , Mesenchymal Stem Cells/metabolism , Osteogenesis, Distraction/methods , Osteogenesis/drug effects , Animals , Bone and Bones/drug effects , Cell Differentiation/drug effects , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunohistochemistry , Intercellular Signaling Peptides and Proteins/metabolism , Intercellular Signaling Peptides and Proteins/pharmacology , Mesenchymal Stem Cell Transplantation , Mice , Mice, Inbred ICR , Osteoblasts/cytology , Osteoblasts/drug effects
10.
Auris Nasus Larynx ; 41(1): 41-5, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23791424

ABSTRACT

OBJECTIVE: A retrospective study of risk factors for recurrent epistaxis and initial treatment for refractory posterior bleeding was performed. Based on the results, proposals for appropriate initial treatment for epistaxis by otolaryngologists are presented. METHODS: The data of 299 patients with idiopathic epistaxis treated during 2008-2009 were analyzed by multivariate logistic regression analysis. Treatment data for 101 cases of posterior bleeding were analyzed using the chi-square test. RESULTS: Recurrent epistaxis occurred in 32 cases (10.7%). Unidentified bleeding point (adjusted odds ratio (OR) 5.67, 95% confidence interval (CI) 1.83-17.55, p=0.003) was predictive of an increased risk of recurrent epistaxis, and electrocautery (adjusted odds ratio (OR) 0.07, 95% confidence interval (CI) 0.03-0.17, p=0.000) was predictive of a decreased risk of recurrent epistaxis. In terms of initial treatment for posterior bleeding, the rate of recurrent epistaxis was significantly lower for patients who underwent electrocautery as initial treatment compared with those who did not (6.4% vs. 40.7%, p<0.01), and it was significantly higher for those who underwent endoscopic gauze packing compared with those who did not (39.5% vs. 15.9%, p<0.01). CONCLUSION: In the present study, the risk factors for recurrent epistaxis were unidentified bleeding point. Thus, it is important to identify and cauterize a bleeding point to prevent recurrent epistaxis. The present results also suggest the effectiveness of electrocautery and the higher rate of recurrent epistaxis for patients who underwent gauze packing as initial treatment for posterior bleeding. Electrocautery should be the first-choice treatment of otolaryngologists for all bleeding points of epistaxis, and painful gauze packing may be inadvisable for posterior bleeding. More cases of posterior bleeding are needed for future studies involving multivariate analyses and appropriate analyses of factors related to hospitalization, surgery, and embolization.


Subject(s)
Epistaxis/therapy , Hemostatic Techniques , Adult , Aged , Electrocoagulation/methods , Endoscopy/methods , Female , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Odds Ratio , Recurrence , Retrospective Studies , Risk Factors , Tampons, Surgical
11.
Laryngoscope ; 123(8): 2050-5, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23576311

ABSTRACT

BACKGROUND AND OBJECTIVES: The phenomena of periodic cycles of vascular engorgement on the nasal cavity mucosa that alternate between right and left sides are termed the "nasal cycle." The physiologic mechanisms underlying this cycle have not been entirely clarified, even more so during sleep. In this study, we measured the periodic patterns of the normal nasal cycle, not only during wakefulness but also during sleep. STUDY DESIGN CASE SERIES METHODS: Our team utilized a method for functional rhinologic assessment, the portable rhinoflowmeter (Rhinocycle, Rhinometrics, Lynge, Denmark), measuring airflow independently through each nostril during 24 hours on 20 healthy subjects aged 20 to 56 years, and without any nasal pathology or diagnosed medical, psychiatric, or sleep disorders. In addition, a nocturnal polysomnogram was simultaneously performed during sleep. RESULTS: Nineteen of 20 subjects showed a detectable nasal cycle, and 16 of 19 subjects presented a change of the cyclic phase during sleep. The mean nasal cycle duration was 234.2 ± 282.4 minutes (median, 164.1 minutes), although variation was considerable. The mean cycle duration time during sleep was significantly longer than that in wakefulness (P <0.005). The reversal of cyclic phase during sleep tended to be associated with REM sleep (68.8%) and postural changes (18.8%). It never occurred in slow-wave sleep. CONCLUSIONS: Nasal cycle duration during sleep is longer than in wakefulness. Changes in laterality of nasal cycle frequently coincide with switches in posture, tend to occur in REM sleep, never occur in slow-wave sleep, and may be absent in subjects with severe nasal septal deviations.


Subject(s)
Nasal Cavity/physiology , Sleep Stages/physiology , Sleep/physiology , Wakefulness/physiology , Adult , Humans , Japan , Male , Middle Aged , Polysomnography , Rhinomanometry , Young Adult
12.
Case Rep Otolaryngol ; 2012: 421065, 2012.
Article in English | MEDLINE | ID: mdl-23304595

ABSTRACT

Acinic cell carcinoma of minor salivary gland of the base of tongue is very rare. Squamous cell carcinoma is the most common tumor in the base of tongue. We present a patient with gigantic acinic cell carcinoma of the base of tongue. This patient required emergency tracheotomy before surgery, because he had dyspnea when he came to our hospital. We removed this tumor by pull-through method and performed reconstructive surgery using a rectus abdominis myocutaneous flap. It was a case that to preserved movement of the tongue and swallowing function by keeping lingual arteries and hypoglossal nerves. This case was an extremely rare case of ACC of the base of tongue that required reconstructive surgery.

13.
Bone ; 49(4): 693-700, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21741502

ABSTRACT

Distraction osteogenesis (DO) is a unique therapy that induces skeletal tissue regeneration without stem/progenitor cell transplantation. Although the self-regeneration property of DO provides many clinical benefits, the long treatment period required is a major drawback. A high-speed DO mouse model (H-DO), in which the distraction was done two times faster than in control DO (C-DO) mice, failed to generate new bone callus in the DO gap. We found that this was caused by the unsuccessful recruitment of bone marrow endothelial cells (BM-ECs)/endothelial progenitor cells (EPCs) into the gap. We then tested the ability of a local application of stromal cell-derived factor-1 (SDF-1), a major chemo-attractant for BM-ECs/EPCs, to accelerate the bone regeneration in H-DO. Our data showed that, in H-DO, SDF-1 induced callus formation in the gap through the recruitment of BM-ECs/EPCs, the maturation of neo-blood vessels, and increased blood flow. These results indicate that the active recruitment of endogenous BM-ECs/EPCs may provide a substantial clinical benefit for shortening the treatment period of DO.


Subject(s)
Bone Regeneration , Chemokine CXCL12/metabolism , Endothelial Cells/cytology , Osteogenesis, Distraction , Stem Cells/cytology , Animals , Blood Vessels/metabolism , Blood Vessels/pathology , Bone Marrow Cells/cytology , Bone Marrow Cells/drug effects , Bone Marrow Cells/metabolism , Bone Regeneration/drug effects , Bone and Bones/blood supply , Bone and Bones/metabolism , Bone and Bones/pathology , Bony Callus/drug effects , Bony Callus/pathology , Chemokine CXCL12/administration & dosage , Chemokine CXCL12/pharmacology , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Female , Humans , Ischemia/pathology , Mice , Mice, Inbred ICR , Models, Animal , Neovascularization, Physiologic/drug effects , Receptors, CXCR/metabolism , Receptors, CXCR4/metabolism , Stem Cells/drug effects , Stem Cells/metabolism , Wound Healing/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...